SteinCares
  • Home
  • Company
    • Who We are
    • Our Milestones
    • Our Presence
  • Business Segments
    • Innovative
    • Biosimilars
    • Complex Generics
    • Therapeutic Areas
  • Partnerships
    • Pillars of Successful Partnerships
    • Our Partnership Solutions
  • Press Releases
  • Contact us
  • ESP
Select Page
CStone Partners with SteinCares to Market Sugemalimab in Latin America

CStone Partners with SteinCares to Market Sugemalimab in Latin America

by victoria.carrillo | Jan 27, 2025 | Press Releases

CStone will receive upfront, regulatory and commercial milestone payments, and book revenue from SteinCares through the supply of sugemalimab in 10 Latin American (LATAM) countries. This marks CStone’s third major global commercialization partnership for...

Recent Posts

  • SteinCares Strengthens its Onco-Hematology Portfolio with the Introduction of Spectrila® in Brazil
  • SteinCares and Shilpa Biologicals Strike into licensing agreement to Expand Access to Biosimilars Across Latin America
  • SteinCares Earns AA Rating from Moody’s, Reflecting Strong Financial Profile, Operational Excellence, and Robust Governance
  • SteinCares Expands its Portfolio in Brazil with Monofer®
  • SteinCares Opens New Facility in Costa Rica to Strengthen Access to Specialty Healthcare Across Latin America

Recent Comments

No comments to show.